Financial Results at Ipsen | Detailed Financial Performance

Financial Results

Q3 2025 Results

Ipsen’s financial results for the first nine months of 2025 will be published on 22 October 2025.

An investor and analyst conference call will follow at 1pm CET.

Register to the investor and analyst conference call

Period

recent search

Reset

Showing: 1 – 05 of 30 Financial Results

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance
 –  21 October 2021

21 October 2021

Download
Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance


Ipsen delivers strong H1 2021 results and upgrades full-year guidance
 –  26 July 2021

26 July 2021

Download
Ipsen delivers strong H1 2021 results and upgrades full-year guidance


Ipsen delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance
 –  22 April 2021

22 April 2021

Download
Ipsen delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance

Attachment


Ipsen delivered sales growth and margin expansion in 2020 – Focused on executing new strategy and delivering financial objectives in 2021
 –  11 February 2021

11 February 2021

Download
Ipsen delivered sales growth and margin expansion in 2020 – Focused on executing new strategy and delivering financial objectives in 2021

Attachment


Ipsen delivers sales growth in the first nine months of 2020 despite the impact of COVID-19 and confirms its 2020 full year guidance
 –  22 October 2020

22 October 2020

Download
Ipsen delivers sales growth in the first nine months of 2020 despite the impact of COVID-19 and confirms its 2020 full year guidance

Paris (France), 22 October 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter of 2020.


Your dedicated contacts